Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermela Shimelis

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 20, 2019
Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohortHongyan Li, Holly LaDuca, Tina Pesaran, et al.
Cancer Cell|April 7, 2009
Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitinationKexin Xu, Hermela Shimelis, Douglas E Linn, et al.
American Journal of Human Genetics|February 4, 2018
Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational ApproachesLucia Guidugli, Hermela Shimelis, David L Masica, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 4, 2018
Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panelsKristy Lee, Bryce A Seifert, Hermela Shimelis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 10, 2018
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction modelsSteven N Hart, Tanya Hoskin, Hermela Shimelis, et al.
JCO Precision Oncology|September 10, 2019
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility GenesChunling Hu, Holly LaDuca, Hermela Shimelis, et al.
Journal of the National Cancer Institute|July 9, 2018
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation StatusSamuel O Antwi, Sarah E Fagan, Kari G Chaffee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerJohanna I Kiiski, Liisa M Pelttari, Sofia Khan, et al.
JAMA Oncology|April 19, 2017
Associations Between Cancer Predisposition Testing Panel Genes and Breast CancerFergus J Couch, Hermela Shimelis, Chunling Hu, et al.
Journal of the National Cancer Institute|November 4, 2020
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast CancerSiddhartha Yadav, Holly LaDuca, Eric C Polley, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 20, 2019
Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohortHongyan Li, Holly LaDuca, Tina Pesaran, et al.
Cancer Cell|April 7, 2009
Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitinationKexin Xu, Hermela Shimelis, Douglas E Linn, et al.
American Journal of Human Genetics|February 4, 2018
Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational ApproachesLucia Guidugli, Hermela Shimelis, David L Masica, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 4, 2018
Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panelsKristy Lee, Bryce A Seifert, Hermela Shimelis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 10, 2018
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction modelsSteven N Hart, Tanya Hoskin, Hermela Shimelis, et al.
JCO Precision Oncology|September 10, 2019
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility GenesChunling Hu, Holly LaDuca, Hermela Shimelis, et al.
Journal of the National Cancer Institute|July 9, 2018
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation StatusSamuel O Antwi, Sarah E Fagan, Kari G Chaffee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerJohanna I Kiiski, Liisa M Pelttari, Sofia Khan, et al.
JAMA Oncology|April 19, 2017
Associations Between Cancer Predisposition Testing Panel Genes and Breast CancerFergus J Couch, Hermela Shimelis, Chunling Hu, et al.
Journal of the National Cancer Institute|November 4, 2020
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast CancerSiddhartha Yadav, Holly LaDuca, Eric C Polley, et al.
Pageof 4